Princeton, New Jersey, United States The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Princeton.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The increased amount of exits for fund were in 2010. The top activity for fund was in 2007. The fund is generally included in less than 2 deals every year.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline REVA Medical We can highlight the next thriving fund investment areas, such as Hardware, Medical Device. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Group Outcome, startups are often financed by Boston Scientific. The meaningful sponsors for the fund in investment in the same round are Pequot Capital, Medtronic, Domain Associates. In the next rounds fund is usually obtained by Senrigan Capital, Goldman Sachs.
Related Funds
| Fund Name | Location |
| A-Grade Investments | California, Los Angeles, United States |
| Hunt Technology Ventures | Dallas, Texas, United States |
| Ibercaja | - |
| Norvestia Growth Equity | Finland, Helsinki, Southern Finland |
| Optus Innov8 | Australia, New South Wales, Sydney |
| Polychain | California, San Francisco, United States |
| SAGANA | Switzerland, Zürich, Zurich |
| Xuanzhang Touzi | China, Guangdong, Shenzhen |
| Zino Ventures | Auckland, Auckland, New Zealand |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 